Conclusion:
Pediatric cancer patients are at risk for transfusional iron overload,
with significant exposure to toxic forms of iron indicated by
extrahepatic iron deposition (pancreas, heart and pituitary). Further
studies should examine the effect of exposure to reactive iron on
long-term outcomes and develop management recommendations.